The effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndrome

Basit Öğe Kaydı
dc.contributor.authorMocan M.C.
dc.contributor.authorUstunel S.
dc.contributor.authorDikmetas O.
dc.contributor.authorBozkurt B.
dc.contributor.authorIrkec M.
dc.date.accessioned2020-03-26T18:59:15Z
dc.date.available2020-03-26T18:59:15Z
dc.date.issued2014
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractPurpose: The purpose of this study was to evaluate the effect of pharmacologic pupillary dilatation on anterior chamber depth (ACD) and anterior chamber angle (ACA) in eyes with exfoliation syndrome (XFS). Methods: Thirty-six eyes of 36 patients with XFS were evaluated with slit-lamp examination, Goldmann applanation tonometry and ultrasound biomicroscopy (UBM) under standard light conditions. Primary outcome parameters were defined as the change in ACD and ACA measured before and 40 min after instillation of a single drop of either 1% cyclopentolate (Group I; n = 12), 2.5% phenylephrine (Group II; n = 12) or 1% tropicamide (Group III; n = 12). Change in intraocular pressure (IOP) during the same time interval was included as a secondary outcome measure. Results: The average predilatation ACD, ACA and IOP values in the study subjects were 2.54 ± 0.40 mm, 27.9 ± 6.3° and 14.9 ± 3.1 mmHg, respectively. There were no significant differences in the mean age (p = 0.461), the female/male ratio (p = 0.232), baseline ACD (p = 0.841), ACA (p = 0.761) or IOP (p = 0.070) within the three groups. Differences in dilation induced changes in ACD (p = 0.108), ACA (p = 0.636) and IOP (p = 0.160) between the three groups were not statistically significant. Conclusion: Pupillary dilatation with a single drop of 1.0% cyclopentolate, 2.5% phenylephrine or 1% tropicamide is not associated with shallowing of the anterior chamber or narrowing of the ACA in patients with XFS who present with open angles. © 2013 Spanish General Council of Optometry.en_US
dc.identifier.doi10.1016/j.optom.2013.05.001en_US
dc.identifier.endpage56en_US
dc.identifier.issn1888-4296en_US
dc.identifier.issue1en_US
dc.identifier.pmid24646901en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage51en_US
dc.identifier.urihttps://dx.doi.org/10.1016/j.optom.2013.05.001
dc.identifier.urihttps://hdl.handle.net/20.500.12395/31465
dc.identifier.volume7en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.relation.ispartofJournal of Optometryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectAnterior chamber angleen_US
dc.subjectAnterior chamber depthen_US
dc.subjectExfoliation syndromeen_US
dc.subjectPupillary dilatationen_US
dc.subjectUltrasound biomicroscopyen_US
dc.titleThe effect of pharmacologic pupillary dilatation on anterior segment parameters in patients with exfoliation syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu